Page last updated: 2024-11-05

thiethylperazine and Autosomal Dominant Juvenile Parkinson Disease

thiethylperazine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Thiethylperazine (Torecan) is a piperazine phenothiazine employed to relieve vertigo."1.32Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade. ( Battistin, L; Briani, C; Cagnin, A; Chierichetti, F; Pizzolato, G; Tiberio, M, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briani, C1
Cagnin, A1
Chierichetti, F1
Tiberio, M1
Battistin, L1
Pizzolato, G1

Other Studies

1 other study available for thiethylperazine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade.
    European journal of neurology, 2004, Volume: 11, Issue:10

    Topics: Basal Ganglia; Benzamides; Brain Mapping; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine I

2004